Literature DB >> 3791624

Catecholamine-induced polyploidization in vascular smooth muscle cells.

Y Yamori, M Mano, Y Nara, R Horie.   

Abstract

Polyploidy formation of vascular smooth muscle cells was observed in vivo by intravenous infusion of norepinephrine or epinephrine in Wistar-Crea rats for 12 days at the rate of 0.02 mumol/hr with an osmotic minipump and in vitro by exposing cultured vascular smooth muscle cells obtained from normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) to norepinephrine (10(-7)M to 10(-5)M) in the cultured medium. Infusion in vivo of norepinephrine but not epinephrine increased blood pressure slightly. However, both agents increased significantly the frequency of tetraploidy of smooth muscle cells up to 14.9 +/- 0.6% (mean +/- SE) and 9.2 +/- 0.5% compared with saline (6.5 +/- 0.7%). Exposure in vitro to norepinephrine (10(-6)M) increased the frequency of tetraploidy and octaploidy of smooth muscle cells from SHR up to 14.2% and 2.1%, respectively, compared with nonexposed cells (8.1% and 0.2%). These results appear to indicate that norepinephrine and epinephrine induce polyploidy of smooth muscle cells independently from blood pressure elevation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3791624

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.

Authors:  G Lembo; R Napoli; B Capaldo; V Rendina; G Iaccarino; M Volpe; B Trimarco; L Saccà
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

2.  Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization.

Authors:  M L Hixon; C Muro-Cacho; M W Wagner; C Obejero-Paz; E Millie; Y Fujio; Y Kureishi; T Hassold; K Walsh; A Gualberto
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 3.  Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.

Authors:  G H Gibbons; V J Dzau
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.